|1.||Burg, Samuel: 1 article (04/2015)|
|2.||Le Guludec, Dominique: 1 article (04/2015)|
|3.||Hyafil, Fabien: 1 article (04/2015)|
|4.||Buvat, Irène: 1 article (04/2015)|
|5.||Huet, Pauline: 1 article (04/2015)|
|6.||Bankstahl, Jens P: 1 article (11/2012)|
|7.||Müller, Markus: 1 article (11/2012)|
|8.||Bankstahl, Marion: 1 article (11/2012)|
|9.||Kuntner, Claudia: 1 article (11/2012)|
|10.||Löscher, Wolfgang: 1 article (11/2012)|
|1.||Lung Neoplasms (Lung Cancer)
|2.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
|3.||Prostatic Neoplasms (Prostate Cancer)
05/01/2009 - "Important components of the proposed PERCIST criteria include assessing normal reference tissue values in a 3-cm-diameter region of interest in the liver, using a consistent PET protocol, using a fixed small region of interest about 1 cm(3) in volume (1.2-cm diameter) in the most active region of metabolically active tumors to minimize statistical variability, assessing tumor size, treating SUV lean measurements in the 1 (up to 5 optional) most metabolically active tumor focus as a continuous variable, requiring a 30% decline in SUV for "response," and deferring to RECIST 1.1 in cases that do not have (18)F-FDG avidity or are technically unsuitable. "
08/01/2011 - "Thus, the PET protocol provides both motion-free images and a spatiotemporal characterization of the glucose distribution in lung tumors. "